Insulet Corp (NASDAQ:PODD)
| Market Cap | 9.25B-57.7% |
| Revenue (ttm) | 3.05B+29.4% |
| Net Income | 375.30M+59.0% |
| EPS | 5.35+62.6% |
| Shares Out | 69.26M |
| PE Ratio | 24.91 |
| Forward PE | 17.32 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 189,012.593 |
| Open | 134.80 |
| Previous Close | 134.36 |
| Day's Range | 133.01 - 134.97 |
| 52-Week Range | 126.40 - 354.88 |
| Beta | 1.10 |
| Analysts | Buy |
| Price Target | 182.35(+36.59%) |
| Earnings Date | Nov 4, 2026 |
INSULET CORP has a live Insider Score.
Scored on 1 qualifying trade from 1 insider in the last 90 days.
About PODD
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$PODD stock is featured in our Insider Score Rankings, Congress Trading, and Insider Trades datasets.
→ All Stock ListsCongress Trading
Recent trades of PODD by members of U.S. Congress
| Politician | Type | Traded |
|---|---|---|
| Gilbert CisnerosHouse / D | Purchase$1.00K – $15.00K | Aug 18, 2026 |
| Gilbert Ray CisnerosHouse / D | Sale$1.00K – $15.00K | Sep 17, 2019 |
| Gilbert CisnerosHouse / D | Sale$1.00K – $15.00K | Sep 17, 2019 |
| Gilbert Ray CisnerosHouse / D | Sale$1.00K – $15.00K | Sep 16, 2019 |
| Josh GottheimerHouse / D | Sale$1.00K – $15.00K | Sep 13, 2019 |
| Gilbert Ray CisnerosHouse / D | Purchase$1.00K – $15.00K | Mar 7, 2019 |
| Gilbert CisnerosHouse / D | Purchase$1.00K – $15.00K | Mar 7, 2019 |
| Gilbert Ray CisnerosHouse / D | Purchase$1.00K – $15.00K | Mar 6, 2019 |
Recently reported changes in PODD holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by PODD's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
PODD Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New PODD patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to PODD from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in PODD
| ETF | Est. Holding Size |
|---|---|
| VTIVanguard Morningstar Total Stock Market ETF | $327.61M |
| VOOVanguard S&P 500 ETF | $273.09M |
| VBVanguard Morningstar Small-Cap ETF | $236.88M |
| RSPInvesco S&P 500 Equal Weight ETF | $189.88M |
| VBKVanguard Morningstar Small-Cap Growth ETF | $136.02M |
| IVViShares Core S&P 500 ETF | $124.13M |
Estimated from each fund’s disclosed top holdings × AUM
PODD Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from PODD’s recent data — informational, not investment advice
Insider Score
Our 0–100 Insider Score and the signals behind it.
The live Insider Score and its full factor breakdown are included with Insider Access.
Unlock Insider Score